Subjects under University of New South Wales
Document Details

ACCT5910 Final Assignment

User Description:
1 Executive Summary CSL develops, manufactures, and sells biopharmaceutical mostly derived from immunoglobulins, a constituent of blood plasma. The compounds treat rare and fatal medical conditions involving the immune system. CSL has a narrow competitive advantage due to low cost of production, a global blood plasma distribution network, and superior intellectual property that allows innovative product development of high-quality therapeutic products for critical medical conditions. The biotechnology industry is expected to grow due to an aging global population, rise of tropical diseases and an increase use of biotech products in developing economies. The positive long term outlook for growth is expected to benefit CSL due to significant investment in R&D, specialty products and spare capacity. The company has maintained positive financial performance over the last 5 years, as evident from sound sales growth, outperforming competitors. It invests more in R&D than the median in the industry, which is expected to allow CSL to expand further with new products. Our analysis of historical accounting data did not reveal any attempts to manipulate earnings or accounting numbers. Management’s intended capital structure, which envisages the buyback of shares is expected to deliver more returns to shareholders. The stock, however, seems relatively expensive using forward valuation models. Our valuation of the stock uses DCF as the primary valuation methodology. Valuation via PE and enterprise values are used as check methodologies. We considered three DCF scenarios, a bear scenario, a base or expected scenario and a bull scenario. The stock price as at 12 May 2017 was $129 as compared to our fair value measure of $131.96. We consider the stock moderately under-valued and recommend BUY at this price. A fair value of up to $153.93 per share is supported by PE multiples. We recommend investors begins to REDUCE their holdings when the price approaches $153.93 and SELL at any price point beyond $161, which is the maximum fair value obtained using trading or EV multiples.

Thinkswap Satisfaction Guarantee

Each document purchased on Thinkswap is covered by our Satisfaction Guarantee policy. If you are not satisfied with the quality of any document, or you believe the document was incorrectly described or categorised, Thinkswap will provide a full refund of exchange credits so you can check out another document. For more information please click here.

This student studied:
Claim a Thinkswap Bounty

Do you know if the Subject listed above has changed recently? Click report to earn free Exchange Credits!

Document Information:
31 Pages Essays / Projects 1-2 Years old
Share

2 Ex Credits


Document Screenshots:
ACCT5910 Final Assignment
Topics this document covers:
Economy Business Valuation Grifols IBEX-35 Financial ratio CSL Behring Inventory turnover Inventory Fundamental analysis CSL Limited Financial analysis
This is an Essay / Project

Essays / Projects are typically greater than 5 pages in length and are assessments that have been previously submitted by a student for academic grading.

What are Exchange Credits:

Exchange Credits represent the worth of each document on Thinkswap. In exchange for uploading documents you will receive credits. These can then be used to checkout other documents on Thinkswap.

Topics this document covers:
Economy Business Valuation Grifols IBEX-35 Financial ratio CSL Behring Inventory turnover Inventory Fundamental analysis CSL Limited Financial analysis
Sample Text:
............................................... 1 1 EXECUTIVE SUMMARY .................................................................................................. 1 2 INDUSTRY ANALYSIS ..................................................................................................... 2 2.1 INDUSTRY OVERVIEW ...................................................................................................... 2 2.1.1 PRODUCTS ........................................................................................................................ 2 2.1.2 MAIN PLAYERS .................................................................................................................. 2 2.1.3 INDUSTRY OUTLOOK ........................................................................................................... 3 3 COMPANY ANALYSIS ..................................................
Similar Documents to ACCT5910 Final Assignment

5910 Assignment 2010

This student studied:
University of New South Wales - ACCT5910 - Business Evaluation

2010 assignment business valuation and analysis of CCL 5910. accounting analysis and so on

2 Ex Credits

View Details

Corporate Finance

This student studied:
University of Melbourne - FNCE30002 - Corporate Finance

Detailed notes and summaries based on the lectures slides, book and extensive independent research

5 Ex Credits

View Details

BUS1AFB Complete Study Notes

This student studied:
La Trobe University - BUS1AFB - Accounting and Finance for Business

These cover all the topics in this course succinctly and with a good level of detail.

5 Ex Credits

View Details

Auditing - Ratio Analysis Table

This student studied:
University of New South Wales - ACCT3708 - Auditing and Assurance Services

Auditing & Assurance Services - Ratio Analysis Table: helped with preparation for quizzes

1 Ex Credit

View Details